Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Adoptive cell therapy, also known as cellular immunotherapy, is a form of treatment that uses the cells of our immune system to eliminate cancer.
Market Analysis and Insights: Global Adoptive Cell Therapy Market
In 2019, the global Adoptive Cell Therapy market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.
Global Adoptive Cell Therapy Scope and Market Size
Adoptive Cell Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Adoptive Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Adoptive Cell Therapy market is segmented into CAR-T, TCR-T, NK, TIL, etc.
Segment by Application, the Adoptive Cell Therapy market is segmented into Lymphoma, Leukemia, etc.
Regional and Country-level Analysis
The Adoptive Cell Therapy market is analysed and market size information is provided by regions (countries).
The key regions covered in the Adoptive Cell Therapy market report are North America, Europe, China, Japan, South Korea and India, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Adoptive Cell Therapy market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Adoptive Cell Therapy business, the date to enter into the Adoptive Cell Therapy market, Adoptive Cell Therapy product introduction, recent developments, etc.
The major vendors include Novartis, Juno, Kite, Adaptimmune, Fibrocell, Lineage Cell Therapeutics, BioTime, Vericel Corporation, Regeneus, Anhui Anke Biotechnology, Cellectis, NantKwest, SorrentoTherapeutics, Bellicum, etc.
This report focuses on the global Adoptive Cell Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Adoptive Cell Therapy development in North America, Europe, China, Japan, South Korea and India.
Novartis
Juno
Kite
Adaptimmune
Fibrocell
Lineage Cell Therapeutics
BioTime
Vericel Corporation
Regeneus
Anhui Anke Biotechnology
Cellectis
NantKwest
SorrentoTherapeutics
Bellicum
CAR-T
TCR-T
NK
TIL
Lymphoma
Leukemia
North America
Europe
China
Japan
South Korea
India
To analyze global Adoptive Cell Therapy status, future forecast, growth opportunity, key market and key players.
To present the Adoptive Cell Therapy development in North America, Europe, China, Japan, South Korea and India.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Adoptive Cell Therapy are as follows:
History Year: 2015-2019
2019
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Market Analysis and Insights: Global Adoptive Cell Therapy Market
In 2019, the global Adoptive Cell Therapy market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.
Global Adoptive Cell Therapy Scope and Market Size
Adoptive Cell Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Adoptive Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Adoptive Cell Therapy market is segmented into CAR-T, TCR-T, NK, TIL, etc.
Segment by Application, the Adoptive Cell Therapy market is segmented into Lymphoma, Leukemia, etc.
Regional and Country-level Analysis
The Adoptive Cell Therapy market is analysed and market size information is provided by regions (countries).
The key regions covered in the Adoptive Cell Therapy market report are North America, Europe, China, Japan, South Korea and India, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Competitive Landscape
and Adoptive Cell Therapy Market Share AnalysisAdoptive Cell Therapy market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Adoptive Cell Therapy business, the date to enter into the Adoptive Cell Therapy market, Adoptive Cell Therapy product introduction, recent developments, etc.
The major vendors include Novartis, Juno, Kite, Adaptimmune, Fibrocell, Lineage Cell Therapeutics, BioTime, Vericel Corporation, Regeneus, Anhui Anke Biotechnology, Cellectis, NantKwest, SorrentoTherapeutics, Bellicum, etc.
This report focuses on the global Adoptive Cell Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Adoptive Cell Therapy development in North America, Europe, China, Japan, South Korea and India.
The key players covered in this study
Novartis
Juno
Kite
Adaptimmune
Fibrocell
Lineage Cell Therapeutics
BioTime
Vericel Corporation
Regeneus
Anhui Anke Biotechnology
Cellectis
NantKwest
SorrentoTherapeutics
Bellicum
Market segment by Type, the product can be split into
CAR-T
TCR-T
NK
TIL
Market segment by Application, split into
Lymphoma
Leukemia
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
South Korea
India
The study objectives of this report are:
To analyze global Adoptive Cell Therapy status, future forecast, growth opportunity, key market and key players.
To present the Adoptive Cell Therapy development in North America, Europe, China, Japan, South Korea and India.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Adoptive Cell Therapy are as follows:
History Year: 2015-2019
Base Year:
2019Estimated Year:
2020Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
